BioCentury
ARTICLE | Top Story

Elan's Martin to extend tenure

March 2, 2012 1:54 AM UTC

Elan Corp. plc (NYSE:ELN) said CEO Kelly Martin will not step down on May 1 as previously announced. Chairman Robert Ingram said in a statement that he asked Kelly to remain as CEO until data from Phase III trials of bapineuzumab for Alzheimer's disease (AD) have been shared publicly, evaluated and assessed. ...